Please use this identifier to cite or link to this item:
|Title:||The fentanyls: pharmacological and clinical aspects relevant to Australia.|
|Authors:||Greene, Shaun L;Scamvougeras, Anton;Norman, Amanda;Bonomo, Yvonne;Castle, David J|
|Affiliation:||Austin Health, Heidelberg, Victoria, Australia|
University of British Columbia, Canada
St Vincent's Hospital Melbourne, Australia
The University of Melbourne, Australia
St Vincent's Hospital, Australia
|Citation:||Australasian Psychiatry 2020; online first: 11 May|
|Abstract:||North American and other jurisdictions have seen an alarming rise in the abuse of the fentanyls, with related overdose deaths. We sought to review this group of drugs to alert Australian psychiatrists and drug and alcohol clinicians to their clinical effects and potential harms. The extreme potency of the fentanyls underlie their lethality. Vigilance and investment from both policy makers and health care providers are required to mitigate harm from a possible future Australian fentanyl epidemic.|
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.